top of page
background_1.png
87-0J4A9814.jpg

Welcome to CAT Genomics

What is CAT Genomics?

Screenshot 2023-01-17 at 19.30.35.png

CATG (Central Asian and Transcaucasian Genomics) is an initiative aiming at understanding the genetic architecture of rare diseases and common neurodegenerative diseases in Central Asia and Transcaucasus (CAT), promote genetic and genomics research in CAT, and increasing access to genetic testing in CAT populations.

The project is led by a team of researchers from the University College London Institute of Neurology and CAT researchers from 6 countries. The current research interest is focused on the following conditions:

  • Rare Paediatric Neurological Diseases

  • Parkinson’s disease

  • Huntington’s disease

  • Spinocerebellar ataxia

  • Dementia, including Alzheimer’s disease

  • Neuromuscular disease

  • ALS

​

CATG is open for other conditions…

Screenshot 2023-10-18 at 18.18.08.png

Our mission is woven with the thread of empowerment, aiming to harness the power of genomics to benefit CAT populations. By democratizing genetic testing, elevating clinical expertise, supporting national initiatives, disseminating knowledge, and nurturing research collaborations, we aspire to elevate the healthcare landscape in CAT. Through these collective efforts, we hope to reshape the future of healthcare delivery, catalyzed by the transformative potential of genomics. 

bottom of page